UNITED STATES

SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

Date of Report: March 11, 2009

(Date of earliest event reported):


INNODATA ISOGEN, INC.
(Exact name of registrant as specified in its charter)


Delaware

0-22196

13-3475943

(State or other jurisdiction of

incorporation)

(Commission File Number)

 

(I.R.S. Employer

Identification No.)


Three University Plaza

Hackensack, NJ 07601

 

07601

(Address of principal executive offices)

(Zip Code)


(201) 371-2828
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02     Results of Operations and Financial Condition.

       On March 11, 2009, Innodata Isogen, Inc. issued a press release announcing its fourth quarter and year end 2008 financial results.  A copy of the press release is attached hereto as Exhibit 99.1.

       In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


Item 9.01     Financial Statements and Exhibits.

99.1      Press release dated March 11, 2009.

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

INNODATA ISOGEN, INC.

 

 
Date: March 11, 2009 By:

 

/s/ Steven L. Ford

Steven L. Ford

Executive Vice President

and Chief Financial Officer

3


INDEX TO EXHIBITS

Exhibit No.

  Description
  99.1   Press Release of Innodata Isogen, Inc., dated March 11, 2009, reporting fourth quarter and year end 2008 financial results.